Analystreport

Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at Raymond James from $25.00 to $29.00. They now have a "strong-buy" rating on the s

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com